KPMG in Precision Medicine

Strategy | Deals | Operations

In the complex and fast-moving Precision Medicines market clients seek advisors who can provide deep scientific, technical and business insights at a local and global level. Part of the Healthcare and Life Sciences Strategy team, our Precision Medicine practice is a leader in this innovative area of medicine across all thacerapeutic areas, in markets around the world, with all relevant stakeholders and fueled by experience across the value chain.

Who we work with

Hospital & Healthcare Systems

Biopharma Companies

Diagnostic & Life Science Tools Companies

Commercial, Academic & Hospital Labs

Private Investors

Dive into our thinking:

Precision Medicine

Navigating innovation in a new normal

Download PDF

KPMG and Diaceutics

Enabling the precision medicine ecosystem

Download PDF

The real keys to innovative deal making in Precision Medicine in 2022

The Real Keys to Innovative Deal Making in Precision Medicine in 2022: Industry leaders Kristin Pothier, KPMG Global Deal Advisory and Strategy Leader for Healthcare and Life Sciences, and Bonnie Anderson, Chairwoman and former CEO of Veracyte, talk about how strategic deals transformed the company and enabled its growth to market leadership. Kristin and Bonnie discuss the end-to-end journey for successful transactions - from strategic planning, through due diligence, integration, and transformation – and offer outlooks for the year ahead.

See us in action

Watch our Precision Medicine leaders talk about the practice and how KPMG is supporting our clients in their deals, and shaping their strategic direction and operations within this innovative industry.

Strategy

The foundation of Precision Medicine (PM) has evolved from the simplicity of ‘right patient, right drug, right time’ to now encompass cutting edge sequencing, diagnostic, and therapeutic technologies that are impacting clinical outcomes for patients. We help our clients solve their most complex strategic problems on a G-LOCAL level – global strategic focus and local level execution, leveraging our deep market knowledge, and powered by a proprietary database.

+3 services
01

Case Study

Defining an organizational and capabilities roadmap for future market leadership for an oncology medical affairs team in a global biopharma client
Download now
02

Case study

Global market assessment of the current and future Precision Medicine landscape to optimize future launch strategies for a global biopharma client
03

Case study

Developing the go-forward strategy for a leading diagnostics company
Download now

Deals

The Precision Medicines deal market is one of the most active and dynamic in the Life Sciences industry. Our Precision Medicines team supports clients across the deal continuum, from front-end ideation and planning, to commercial, financial and operational due diligence, and through integration and separation. Our practice has been on the buy and sell-side for deals in the Precision Medicine ecosystem for both corporate and private entities.

+3 services
01

Case study

Assessing the commercial viability and investment thesis of an early-stage oncology diagnostics company
Download now
02

Case study

Identifying M&A targets for a leading diagnostics company
Download now
03

Case study

Assessing the commercial viability of assets across multiple indications for a royalty rights opportunity
Download now

Operations

Operating a high-performing organization in the Precision Medicine space requires enabling capabilities and functions to bridge strategy through execution, to keep pace with regulatory changes and the evolution of technology. KPMG leverages a holistic approach, helping organizations design and align operating models with business strategy, positioning the mid- and back-office functions of Precision Medicine organizations for performance transformation and commercial success.

+3 services
01

Case study

Current state assessment and gap analysis to design an improved maarket access governance model for a global biopharma
Download now
02

Case study

Setting up COVID-19 testing capabilities for one of the largest reference labs in the United States
Download now
03

Case study

Post-merger operational enablement of a genomics diagnostic acquisition
Download now

Thriving in a converging environment: learn how KPMG can help pharmaceutical, medical device and diagnostic companies turn disruption into opportunity.

Learn more

Alasdair Milton

Principal, Healthcare and Life Sciences Strategy, KPMG US

Read bio

Puja Ghelani

Director, Healthcare and Life Sciences Strategy, KPMG US

Read bio

Kristin Ciriello Pothier

Life Sciences Sector Leader and Global and U.S. Life Sciences Deal Advisory and Strategy Leader, KPMG LLP

Read bio

Alasdair Milton

Principal, Healthcare and Life Sciences Strategy, KPMG US

Read bio

Puja Ghelani

Director, Healthcare and Life Sciences Strategy, KPMG US

Read bio

Kristin Ciriello Pothier

Life Sciences Sector Leader and Global and U.S. Life Sciences Deal Advisory and Strategy Leader, KPMG LLP

Read bio

Service

Managed services for procurement

Service

Technical accounting on-call services

Service

KPMG Resolve

Service

Orchestrate your human + AI workforce with KPMG Mystro

Relevant Results

KPMG in Precision Medicine

Who we work with

Hospital & Healthcare Systems

Biopharma Companies

Diagnostic & Life Science Tools Companies

Commercial, Academic & Hospital Labs

Private Investors

Dive into our thinking:

Explore more

The real keys to innovative deal making in Precision Medicine in 2022

See us in action

Explore our services

Related insights

Life Sciences

Meet our team

Explore other services tailored to your business

Contact KPMG

Headline